304 related articles for article (PubMed ID: 15512960)
1. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
Gebhardt BM; Kaufman HE; Hill JM
Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
[TBL] [Abstract][Full Text] [Related]
2. Acetylsalicylic acid reduces viral shedding induced by thermal stress.
Gebhardt BM; Varnell ED; Kaufman HE
Curr Eye Res; 2004; 29(2-3):119-25. PubMed ID: 15512958
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
[TBL] [Abstract][Full Text] [Related]
4. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.
Sawtell NM; Bernstein DI; Stanberry LR
J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
6. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 2005 Apr; 21(2):114-20. PubMed ID: 15857277
[TBL] [Abstract][Full Text] [Related]
8. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
Higaki S; Watanabe K; Itahashi M; Shimomura Y
Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
11. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
12. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
13. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
[TBL] [Abstract][Full Text] [Related]
14. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
16. A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model.
Marquart ME; Zheng X; Tran RK; Thompson HW; Bloom DC; Hill JM
Virology; 2001 May; 284(1):62-9. PubMed ID: 11352668
[TBL] [Abstract][Full Text] [Related]
17. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
18. Propranolol suppresses reactivation of herpesvirus.
Gebhardt BM; Kaufman HE
Antiviral Res; 1995 Jun; 27(3):255-61. PubMed ID: 8540747
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
20. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus.
Stroop WG; Schaefer DC
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
